Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evidence-Based Longevity Interventions and Targeted Engagement (E.L.I.T.E.)
NCT07871799Phase 2Completed
- Sponsor
- Sheba Medical Center
- Start
- Nov 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide, empagliflozin in healthy aging, sponsored by Sheba Medical Center. Started Nov 2025; status: completed.
02
Drugs
semaglutideempagliflozin
03
Conditions
healthy aging
Beyond the preview
Go deeper on NCT07871799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871799.